[go: up one dir, main page]

NO874056D0 - Analysefremgangsmaate og diagnostisk system for en markoer for unormal lipidmetabolisme. - Google Patents

Analysefremgangsmaate og diagnostisk system for en markoer for unormal lipidmetabolisme.

Info

Publication number
NO874056D0
NO874056D0 NO874056A NO874056A NO874056D0 NO 874056 D0 NO874056 D0 NO 874056D0 NO 874056 A NO874056 A NO 874056A NO 874056 A NO874056 A NO 874056A NO 874056 D0 NO874056 D0 NO 874056D0
Authority
NO
Norway
Prior art keywords
market
analysis
diagnostic system
lipid metabolism
abnormal lipid
Prior art date
Application number
NO874056A
Other languages
English (en)
Other versions
NO874056L (no
NO173902C (no
NO173902B (no
Inventor
Richard S Smith
Doreen M Hogle
Linda K Curtiss
Joseph L Witztum
Steven Young
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of NO874056D0 publication Critical patent/NO874056D0/no
Publication of NO874056L publication Critical patent/NO874056L/no
Publication of NO173902B publication Critical patent/NO173902B/no
Publication of NO173902C publication Critical patent/NO173902C/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Arrangements For Transmission Of Measured Signals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO874056A 1986-09-29 1987-09-28 Fremgangsmaate for immunologisk paavisning av en markoer for unormal lipidmetabolisme og diagnostisk system for utfoerelse av fremgangsmaaten NO173902C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/913,140 US4828986A (en) 1986-09-29 1986-09-29 Assay method and diagnostic system for determining the ratio of APO B-100 to APO A-I in a blood sample

Publications (4)

Publication Number Publication Date
NO874056D0 true NO874056D0 (no) 1987-09-28
NO874056L NO874056L (no) 1988-03-30
NO173902B NO173902B (no) 1993-11-08
NO173902C NO173902C (no) 1994-02-16

Family

ID=25432962

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874056A NO173902C (no) 1986-09-29 1987-09-28 Fremgangsmaate for immunologisk paavisning av en markoer for unormal lipidmetabolisme og diagnostisk system for utfoerelse av fremgangsmaaten

Country Status (17)

Country Link
US (1) US4828986A (no)
EP (1) EP0262854B1 (no)
JP (1) JP2656774B2 (no)
AT (1) ATE85435T1 (no)
AU (1) AU611096B2 (no)
CA (1) CA1285869C (no)
DE (1) DE3783991T2 (no)
DK (1) DK173724B1 (no)
ES (1) ES2053555T3 (no)
FI (1) FI89214C (no)
GR (1) GR3008027T3 (no)
IE (1) IE60119B1 (no)
IL (1) IL83938A (no)
NO (1) NO173902C (no)
NZ (1) NZ221941A (no)
PT (1) PT85827B (no)
ZA (1) ZA876970B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE120233T1 (de) * 1986-08-06 1995-04-15 Scripps Clinic Res Monoklonale antikörper, b-spezifisch für apolipoprotein, die von zwei hybridomen erzeugt werden.
DE3734015A1 (de) * 1987-10-08 1989-04-20 Behringwerke Ag Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b
AU621575B2 (en) * 1987-11-02 1992-03-19 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai
US5759774A (en) * 1988-05-18 1998-06-02 Cobe Laboratories, Inc. Method of detecting circulating antibody types using dried or lyophilized cells
US5183738A (en) * 1988-09-29 1993-02-02 Japan Immuno Research Laboratories Co., Ltd. Kit for the detection of denatured lipoproteins
US5179008A (en) * 1989-02-09 1993-01-12 Wisconsin Alumni Research Foundation Hybridoma and monoclonal antibody to FHAP
US5473039A (en) * 1989-08-18 1995-12-05 The Scripps Research Institute Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs
US5168045A (en) * 1989-08-18 1992-12-01 The Scripps Research Institute Diagnostic systems and methods using polypeptide analogs of apolipoprotein e
AU662885B2 (en) * 1990-06-07 1995-09-21 Scripps Research Institute, The APO AI polypeptides, antibodies, and immunoassays
WO1992009893A1 (en) * 1990-11-29 1992-06-11 Carbaugh John E DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS AND METHODS FOR LIPOPROTEIN(a)
US5844097A (en) * 1990-11-30 1998-12-01 Monoclonetics International, Inc. Methods for the diagnosis of peripheral nerve damage
DK0559795T3 (da) * 1990-11-30 1996-01-29 Monoclonetics Int Fremgangsmåder til diagnosticering af kroniske smerter i lænderegionen og halshvrivelsøjlen
US5408038A (en) * 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
WO1994007146A1 (en) * 1992-09-24 1994-03-31 Perseptive Biosystems, Inc. Quantitative measurement of ldl
US6107045A (en) * 1994-06-30 2000-08-22 Oklahoma Medical Research Foundation Antibodies to lipoproteins and apolipoproteins and methods of use thereof
US5994061A (en) * 1995-09-29 1999-11-30 Queen's University At Kingston DNA constructs and methods for screening for increased expression of human apo AI gene
US5741647A (en) * 1996-02-16 1998-04-21 Tam; Joseph Wing On Flow through nucleic acid hybridisation uses thereof and a device thereof
US6248539B1 (en) 1997-09-05 2001-06-19 The Scripps Research Institute Porous semiconductor-based optical interferometric sensor
EP0911344B1 (en) 1997-10-15 2004-03-03 Fujirebio Inc. Anti-Apo-B-48 monoclonal antibody, hybridoma, and methods of use
AT5044U1 (de) * 2001-05-10 2002-02-25 Medsystems Diagnostics Gmbh Quantitativer einschritt immuntest in lyophilisierter form
DE60237455D1 (de) * 2001-07-12 2010-10-07 Kyowa Medex Co Ltd Verfahren zur quantifizierung von denaturiertem lipoprotein
US7781171B2 (en) 2003-10-15 2010-08-24 Daiichi Pure Chemicals Co., Ltd. Mehod of pretreating sample and immunological assay method using the same
JP4669929B2 (ja) * 2003-10-15 2011-04-13 積水メディカル株式会社 試料の前処理方法及びこれを利用する免疫学的測定方法
US7521248B2 (en) * 2007-04-20 2009-04-21 Atherotech, Inc. Apo B measurement system and method
EP3435089A1 (en) 2011-11-11 2019-01-30 Axis-Shield AS Determination of non-hdl cholesterol in blood
CN118047854B (zh) * 2024-02-26 2024-08-02 武汉鹰达生物科技有限公司 一种人载脂蛋白a-i的分离纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2061282B (en) * 1979-10-22 1983-03-30 Symphar Sa Method for the clinical separation of a-and lipoproteins and kit for carrying out this method
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
JPS60193926A (ja) * 1984-03-15 1985-10-02 Tokyo Daigaku 単クローン性抗ヒトアポリポ蛋白質ｂ１００抗体
JPS60253871A (ja) * 1984-05-30 1985-12-14 Nippon Koutai Kenkyusho:Kk 抗アポａ−１抗体
EP0209543A4 (en) * 1984-12-31 1989-07-11 Internat Genetic Engineering I FRAGMENTS OF HUMAN APOLIPOPROTEINS PEPTIDES, TYPE-SPECIFIC ANTIBODIES AND METHODS OF USE.
US4677057A (en) * 1985-03-11 1987-06-30 Scripps Clinic And Research Foundation Diagnostic assay for the presence of apolipoproteins associated with plasma high density lipoproteins

Also Published As

Publication number Publication date
ES2053555T3 (es) 1994-08-01
ATE85435T1 (de) 1993-02-15
GR3008027T3 (no) 1993-09-30
DE3783991D1 (de) 1993-03-18
US4828986A (en) 1989-05-09
FI874253L (fi) 1988-03-30
FI89214C (fi) 1993-08-25
NZ221941A (en) 1989-05-29
NO874056L (no) 1988-03-30
DK509287D0 (da) 1987-09-28
IE872605L (en) 1988-03-29
EP0262854A2 (en) 1988-04-06
PT85827B (pt) 1990-08-31
NO173902C (no) 1994-02-16
AU7902887A (en) 1988-03-31
PT85827A (en) 1987-10-01
EP0262854B1 (en) 1993-02-03
NO173902B (no) 1993-11-08
IE60119B1 (en) 1994-06-01
DE3783991T2 (de) 1993-06-09
JP2656774B2 (ja) 1997-09-24
DK173724B1 (da) 2001-07-30
IL83938A0 (en) 1988-02-29
CA1285869C (en) 1991-07-09
ZA876970B (en) 1988-03-21
FI89214B (fi) 1993-05-14
DK509287A (da) 1988-03-30
IL83938A (en) 1991-12-15
JPS63277968A (ja) 1988-11-15
EP0262854A3 (en) 1989-12-06
AU611096B2 (en) 1991-06-06
FI874253A0 (fi) 1987-09-28

Similar Documents

Publication Publication Date Title
NO874056D0 (no) Analysefremgangsmaate og diagnostisk system for en markoer for unormal lipidmetabolisme.
AU7902987A (en) Hybridomas and monoclonal paratopic molecules to apolipoprotein A-1
DE69524092D1 (de) Fraktionierungsverfahren für saccharose enthaltende lösungen
IT8424278A0 (it) Metodo ed apparecchiatura per la distillazione simulata mediante gas-cromatografia con iniezione diretta non vaporizzante.
Morrison et al. The nature of the heterogeneity of prothrombin during dicoumarol therapy
PT1015568E (pt) Metodo para a producao de rdspa alfa1
Hannestad et al. Multiple M-components in a single individual-iI studies on urinary Fab μ like fragments in macroglobulinema
Lasne et al. Radioimmunofixation of human ferritin following serum isoelectric focusing
Rapacz Jr et al. 319 Plasminogen polymorphism in swine
Bøg-Hansen et al. BACTERIAL LIPOPOLYSACCHARIDES INDUCE CHANGES IN LIPOPROTEIN AND ACUTE PHASE PROTEINS IN C3H/HeJ ‘NON-RESPONDER’MICE
KR880001805A (ko) 조 임파구 인터페론의 정제방법